Clinical Trial Detail

NCT ID NCT03207334
Title iCare4: Genomic Signatures With Midostaurin in Acute Myeloid Leukemia (UF-BMT-AML-001)
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Florida
Indications

acute myeloid leukemia

Therapies

Cytarabine + Midostaurin

Age Groups: adult senior

No variant requirements are available.